The role of CXCR5 and its ligand CXCL13 in the compartmentalization of lymphocytes in thyroids affected by autoimmune thyroid diseases

European Journal of Endocrinology

Volumn 150, Issue 2, 2004, Pages 225-234

  Aust, G ^a   Sittig, D ^a   Becherer, L ^a   Anderegg, U ^a   Schutz A ^a   Lamesch, P ^a   Schmucking E ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; CD4 ANTIGEN; CHEMOKINE RECEPTOR CXCR5; COMPLEMENTARY DNA; LIGAND; MESSENGER RNA; THYROID PEROXIDASE; THYROTROPIN RECEPTOR ANTIBODY;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; CELL COMPARTMENTALIZATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FLOW CYTOMETRY; GERMINAL CENTER; GRAVES DISEASE; HASHIMOTO DISEASE; HELPER CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTIC INFILTRATION; MALE; MEMORY CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; THYROID DISEASE; THYROID FOLLICLE CELL; THYROID GLAND;

ADULT; B-LYMPHOCYTE SUBSETS; CHEMOKINES, CXC; CHORISTOMA; FEMALE; GRAVES DISEASE; HUMANS; LEUKEMIC INFILTRATION; LYMPHOID TISSUE; MALE; MIDDLE AGED; RECEPTORS, CHEMOKINE; RECEPTORS, CYTOKINE; REFERENCE VALUES; T-LYMPHOCYTE SUBSETS; THYROID GLAND; THYROIDITIS, AUTOIMMUNE; TISSUE DISTRIBUTION;

EID: 1542300299     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1500225     Document Type: Article

References (42)

1. Forster R, Mattis AE, Kremmer E, Wolf E, Brem G & Lipp M. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 1996 87 1037-1047.
2. Ansel KM, Ngo VN, Hyman PL, Luther SA, Forster R, Sedgwick JD, Browning JL, Lipp M & Cyster JG. A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature 2000 406 309-314.
3. Voigt I, Camacho SA, de Boer BA, Lipp M, Forster R & Berek C. CXCR5-deficient mice develop functional germinal centers in the splenic T cell zone. European Journal of Immunology 2000 30 560-567.
4. Legler DF, Loetscher M, Roos RS, Clark-Lewis I, Baggiolini M & Moser B. B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5. Journal of Experimental Medicine 1998 187 655-660.
5. Forster R, Emrich T, Kremmer E & Lipp M. Expression of the G-protein-coupled receptor BLR1 defines mature, recirculating B cells and a subset of T-helper memory cells. Blood 1994 84 830-840.
6. Schaerli P, Loetscher P & Moser B. Cutting edge: induction of follicular homing precedes effector Th cell development. Journal of Immunology 2001 167 6082-6086.
7. Moser B, Schaerli P & Loetscher P. CXCR5(+) T cells: follicular homing takes center stage in T-helper-cell responses. Trends in Immunology 2002 23 250-254.
8. Breitfeld D, Ohl L, Kremmer E, Ellwart J, Sallusto F, Lipp M & Forster R. Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production. Journal of Experimental Medicine 2000 192 1545-1552.
9. Shi K, Hayashida K, Kaneko M, Hashimoto J, Tomita T, Lipsky PE, Yoshikawa H & Ochi T. Lymphoid chemokine B cell-attracting chemokine-1 (CXCL13) is expressed in germinal center of ectopic lymphoid follicles within the synovium of chronic arthritis patients. Journal of Immunology 2001 166 650-655.
10. Weyand CM & Goronzy JJ. Ectopic germinal center formation in rheumatoid synovitis. Annals of the New York Academy of Sciences 2003 987 140-149.
11. Amft N, Curnow SJ, Scheel-Toellner D, Devadas A, Oates J, Crocker J, Hamburger J, Ainsworth J, Mathews J, Salmon M, Bowman SJ & Buckley CD. Ectopic expression of the B cell-attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center-like structures in Sjogren's syndrome. Arthritis and Rheumatism 2001 44 2633-2641.
12. Carlsen HS, Baekkevold ES, Johansen FE, Haraldsen G & Brandtzaeg P. B cell attracting chemokine 1 (CXCL13) and its receptor CXCR5 are expressed in normal and aberrant gut associated lymphoid tissue. Gut 2002 51 364-371.
13. Warford A, McLachlan SM, Malcolm AJ, Young ET, Farndon JR & Rees Smith B. Characterization of lymphoid cells in the thyroid of patients with Graves' disease. Clinical and Experimental Immunology 1984 57 626-632.
14. Jeong HJ, Lee MK, Choi IJ & Lee YB. Distribution of lymphocytic subpopulations infiltrated in thyroid glands of Graves' disease. Yonsei Medical Journal 1989 30 118-124.
15. Ashhab Y, Dominguez O, Sospedra M, Roura-Mir C, Lucas-Martin A & Pujol-Borrell R. A one-tube polymerase chain reaction protocol demonstrates CC chemokine overexpression in Graves' disease glands. Journal of Clinical Endocrinology and Metabolism 1999 84 2873-2882.
16. Simchen C, Lehmann I, Sittig D, Steinert M & Aust G. Expression and regulation of regulated on activation, normal T cells expressed and secreted in thyroid tissue of patients with Graves' disease and thyroid autonomy and in thyroid-derived cell populations. Journal of Clinical Endocrinology and Metabolism 1999 85 4764.
17. Armengol MP, Juan M, Lucas-Martin A, Fernandez-Figueras MT, Jaraquemada D, Gallart T & Pujol-Borrell R. Thyroid autoimmune disease: demonstration of thyroid antigen-specific B cells and recombination-activating gene expression in chemokine-containing active intrathyroidal germinal centers. American Journal of Pathology 2001 159 861-873.
18. Aust G, Sittig D, Steinert M, Lamesch P & Lohmann T. Graves' disease is associated with an altered CXCR3 and CCR5 expression in thyroid-derived compared to peripheral blood lymphocytes. Clinical and Experimental Immunology 2002 127 479-485.
19. Armengol MP, Cardoso-Schmidt CB, Fernandez M, Ferrer X, Pujol-Borrell R & Juan M. Chemokines determine local lymphoneogenesis and a reduction of circulating CXCR4(+) T and CCR7 B and T lymphocytes in thyroid autoimmune diseases. Journal of Immunology 2003 170 6320-6328.
20. Aust G, Becherer L, Sittig D, Lamesch P & Schmücking E. The role of CXCR5 and its ligand CXCL13 in the compartmentalization of lymphocytes in thyroids affected by Grave's disease. In Sixth European Congress of Endocrinology 26-30.4.2003, Lyon, France 2003, [abstract].
21. Garcia-Lopez MA, Sancho D, Sanchez-Madrid F & Marazuela M. Thyrocytes from autoimmune thyroid disorders produce the chemokines IP-10 and Mig and attract CXCR3 + lymphocytes. Journal of Clinical Endocrinology and Metabolism 2001 86 5008-5016.
22. Aust G, Steinert M, Boltze C, Kiessling S & Simchen C. GRO-alpha in normal and pathological thyroid tissues and its regulation in thyroid-derived cells. Journal of Endocrinology 2001 170 513-520.
23. Kemp EH, Metcalfe RA, Smith KA, Woodroofe MN, Watson PF & Weetman AP. Detection and localization of chemokine gene expression in autoimmune thyroid disease. Clinical Endocrinology 2003 59 207-213.
24. Aust G, Steinert M, Kiessling S, Kamprad M & Simchen C. Reduced expression of Stromal-derived factor 1 in autonomous thyroid adenomas and its regulation in thyroid-derived cells. Journal of Clinical Endocrinology and Metabolism 2001 86 3368-3376.
25. Pritchard J, Horst N, Cruikshank W & Smith TJ. Igs from patients with Graves' disease induce the expression of T cell chemoattractants in their fibroblasts. Journal of Immunology 2002 168 942-950.
26. Köhler T, Schill C, Deininger MW, Krahl R, Borchert S, Hasenclever D, Leiblein S, Wagner O & Niederwieser D. High Bad and Bax mRNA expression correlate with negative outcome in acute myeloid leukemia (AML). Leukemia 2002 16 22-29.
27. Petrasch S, Perez-Alvarez C, Schmitz J, Kosco M & Brittinger G. Antigenic phenotyping of human follicular dendritic cells isolated from nonmalignant and malignant lymphatic tissue. European Journal of Immunology 1990 20 1013-1018.
28. Muller G, Hopken UE, Stein H & Lipp M. Systemic immunoregulatory and pathogenic functions of homeostatic chemokine receptors. Journal of Leukocyte Biology 2002 72 1-8.
29. Sallusto F, Kremmer E, Palermo B, Hoy A, Ponath P, Qin S, Forster R, Lipp M & Lanzavecchia A. Switch in chemokine receptor expression upon TCR stimulation reveals novel homing potential for recently activated T cells. European Journal of Immunology 1999 29 2037-2045.
30. Moser B & Ebert L. Lymphocyte traffic control by chemokines: follicular B helper T cells. Immunology Letters 2003 85 105-112.
31. Ishikawa N, Eguchi K, Ueki Y, Nakashima M, Shimada H, Ito K & Nagataki S. Expression of adhesion molecules on infiltrating T cells in thyroid glands from patients with Graves' disease. Clinical and Experimental Immunology 1993 94 363-370.
32. Calame KL, Lin KI & Tunyaplin C. Regulatory mechanisms that determine the development and function of plasma cells. Annual Review of Immunology 2003 21 205-230.
33. Salomonsson S, Larsson P, Tengner P, Mellquist E, Hjelmstrom P & Wahren-Herlenius M. Expression of the B cell-attracting chemokine CXCL13 in the target organ and autoantibody production in ectopic lymphoid tissue in the chronic inflammatory disease Sjogren's syndrome. Scandinavian Journal of Immunology 2002 55 336-342.
34. Mazzucchelli L, Blaser A, Kappeler A, Scharli P, Laissue JA, Baggiolini M & Uguccioni M. BCA-1 is highly expressed in Helicobacter pylori-induced mucosa-associated lymphoid tissue and gastric lymphoma. Journal of Clinical Investigation 1999 104 49-54.
35. Takemura S, Braun A, Crowson C, Kurtin PJ, Cofield RH, O'Fallon WM, Goronzy JJ & Weyand CM. Lymphoid neogenesis in rheumatoid synovitis. Journal of Immunology 2001 167 1072-1080.
36. Kabel PJ, Voorbij HAM, De Haan-Meulman M, van der Gaag RD & Drexhage HA. Intrathyroidal dendritic cells. Journal of Clinical Endocrinology and Metabolism 1988 66 199-207.
37. Paschke R, Vogg M, Swillens S & Usadel KH. Correlation of microsomal antibodies with the intensity of the intrathyroidal autoimmune process in Graves' disease. Journal of Clinical Endocrinology and Metabolism 1993 77 939-943.
38. Weetman AP, McGregor AM, Wheeler MH & Hall R. Extrathyroidal sites of autoantibody synthesis in Graves' disease. Clinical and Experimental Immunology 1984 56 330-336.
39. Chiovato L, Latrofa F, Braverman LE, Pacini F, Capezzone M, Masserini L, Grasso L & Pinchera A. Disappearance of Immoral thyroid autoimmunity after complete removal of thyroid antigens. Annals of Internal Medicine 2003 139 346-351.
40. McLachlan SM, Fawcett J, Atherton MC, Thompson P, Baylis P & Smith BR. Thyroid autoantibody synthesis by cultures of thyroid and peripheral blood lymphocytes. II Effect of thyroglobulin on thyroglobulin antibody synthesis. Clinical and Experimental Immunology 1983 52 620-628.
41. Voorby HA, Kabel PJ, de Haan M, Jeucken PH, van der Gaag RD, de Baets MH & Drexhage HA. Dendritic cells and class II MHC expression on thyrocytes during the autoimmune thyroid disease of the BB rat. Clinical and Immunological Immunopathology 1990 55 9-22.
42. Weyand CM, Kurtin PJ & Goronzy JJ. Ectopic lymphoid organogenesis: a fast track for autoimmunity. American Journal of Pathology 2001 159 787-793.